ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
ScienceAlert on MSN
Popular Anti-Aging Supplement May Fuel Cancer Growth – Here's Why
Scientists have discovered another mechanism through which cancer cells thrive. (Koto_feja/E+/Getty Images) A group of natural compounds attracting attention for their anti-aging potential has a dark ...
The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer ...
Oxford, UK - March 17, 2026. Enara Bio, a pioneer in Dark Antigen® discovery and bispecific T cell engager innovation, today ...
This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...
Morning Overview on MSN
Study links beta cell cholecystokinin to obesity-driven pancreatic cancer
Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
Dec 29 (Reuters) - Genmab (GMAB.CO), opens new tab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish drugmaker said on Monday. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results